Doris A. Taylor - Publications

Affiliations: 
Duke University, Durham, NC 
Area:
Biomedical Engineering

119 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Hochman-Mendez C, Mesquita FCP, Morrissey J, da Costa EC, Hulsmann J, Tang-Quan K, Xi Y, Lee PF, Sampaio LC, Taylor DA. Restoring anatomical complexity of a left ventricle wall as a step toward bioengineering a human heart with human induced pluripotent stem cell-derived cardiac cells. Acta Biomaterialia. PMID 34936938 DOI: 10.1016/j.actbio.2021.12.016  0.378
2021 Bolli R, Mitrani RD, Hare JM, Pepine CJ, Perin EC, Willerson JT, Traverse JH, Henry TD, Yang PC, Murphy MP, March KL, Schulman IH, Ikram S, Lee DP, O'Brien C, ... ... Taylor DA, et al. A Phase II Study of Autologous Mesenchymal Stromal Cells and c-kit Positive Cardiac Cells, Alone or in Combination, in Patients with Ischemic Heart Failure: The CCTRN CONCERT-HF Trial. European Journal of Heart Failure. PMID 33811444 DOI: 10.1002/ejhf.2178  0.308
2020 Tang-Quan KR, Xi Y, Hochman-Mendez C, Xiang Q, Lee PF, Sampaio LC, Taylor DA. Gelatin Promotes Cell Retention Within Decellularized Heart Extracellular Matrix Vasculature and Parenchyma. Cellular and Molecular Bioengineering. 13: 633-645. PMID 33281992 DOI: 10.1007/S12195-020-00634-Z  0.413
2020 Wang X, Chacon LI, Derakhshandeh R, Rodriguez HJ, Han DD, Kostyushev DS, Henry TD, Traverse JH, Moyé L, Simari RD, Taylor DA, Springer ML. Impaired therapeutic efficacy of bone marrow cells from post-myocardial infarction patients in the TIME and LateTIME clinical trials. Plos One. 15: e0237401. PMID 32841277 DOI: 10.1371/Journal.Pone.0237401  0.412
2020 Hochman-Mendez C, Curty E, Taylor DA. Change the Laminin, Change the Cardiomyocyte: Improve Untreatable Heart Failure. International Journal of Molecular Sciences. 21. PMID 32825544 DOI: 10.3390/Ijms21176013  0.351
2020 Hochman-Mendez C, Pereira de Campos DB, Pinto RS, Mendes BJDS, Rocha GM, Monnerat G, Weissmuller G, Sampaio LC, Carvalho AB, Taylor DA, de Carvalho ACC. Tissue-engineered human embryonic stem cell-containing cardiac patches: evaluating recellularization of decellularized matrix. Journal of Tissue Engineering. 11: 2041731420921482. PMID 32742631 DOI: 10.1177/2041731420921482  0.396
2020 Woo YJ, Yau TM, Pan S, Borow K, Milano C, Taylor D, Chang H, Lala A, Acker M, Selzman C, Kern J, Hung J, O'Gara PT, Rose E, Itescu S, et al. Mesenchymal Precursor Cells In Lvad Recipients: Does Hf Etiology Make A Difference? Journal of the American College of Cardiology. 75: 666. DOI: 10.1016/S0735-1097(20)31293-6  0.311
2019 Yang D, O'Brien CG, Ikeda G, Traverse JH, Taylor DA, Henry TD, Bolli R, Yang PC. Meta-analysis of short- and long-term efficacy of mononuclear cell transplantation in patients with myocardial infarction. American Heart Journal. 220: 155-175. PMID 31821904 DOI: 10.1016/J.Ahj.2019.09.005  0.386
2019 Taylor DA, Hochman-Mendez C, Sampaio LC. Are we close to bioengineering a human-sized, functional heart? The Journal of Thoracic and Cardiovascular Surgery. PMID 31668610 DOI: 10.1016/J.Jtcvs.2019.06.135  0.323
2019 Grigorian Shamagian L, Madonna R, Taylor D, Climent AM, Prosper F, Bras-Rosario L, Bayes-Genis A, Ferdinandy P, Fernández-Avilés F, Izpisua Belmonte JC, Fuster V, Bolli R. Perspectives on Directions and Priorities for Future Preclinical Studies in Regenerative Medicine. Circulation Research. 124: 938-951. PMID 30870121 DOI: 10.1161/Circresaha.118.313795  0.437
2019 Taylor DA. The Future of Tissue Engineering in Heart Transplantation. Texas Heart Institute Journal. 46: 73-74. PMID 30833850 DOI: 10.14503/Thij-18-6748  0.357
2019 Paccola Mesquita FC, Hochman-Mendez C, Morrissey J, Sampaio LC, Taylor DA. Laminin as a Potent Substrate for Large-Scale Expansion of Human Induced Pluripotent Stem Cells in a Closed Cell Expansion System. Stem Cells International. 2019: 9704945. PMID 30805013 DOI: 10.1155/2019/9704945  0.35
2019 Broda C, Smith PA, Wang Y, Frazier OH, Dreyer WJ, Adachi I, Taylor DA, Sampaio LC. Hemodynamic Improvement with Application of Mechanical Circulatory Support in Heart Failure with Preserved Ejection Fraction in a Mock Circulation Loop Journal of Heart and Lung Transplantation. 38. DOI: 10.1016/J.Healun.2019.01.949  0.324
2019 Wang Y, Smith PA, Wheeler JR, John MM, Broda CR, Frazier OH, Taylor DA, Sampaio LC. A 4-Chamber Model Heart with 3D Printed Silicone Aorta and Peripheral Arteries to Simulate the Human Cardiovascular System in a Mock Circulatory Loop Journal of Heart and Lung Transplantation. 38. DOI: 10.1016/J.Healun.2019.01.866  0.359
2018 Taylor DA, Sampaio LC, Cabello R, Elgalad A, Parikh R, Wood RP, Myer KA, Yeh AT, Lee PF. Decellularization of Whole Human Heart Inside a Pressurized Pouch in an Inverted Orientation. Journal of Visualized Experiments : Jove. PMID 30531712 DOI: 10.3791/58123  0.406
2018 Fanaroff AC, Morrow V, Krucoff MW, Seltzer JH, Perin EC, Taylor DA, Miller LW, Zeiher AM, Fernández-Avilés F, Losordo DW, Henry TD, Povsic TJ. A Path Forward for Regenerative Medicine. Circulation Research. 123: 495-505. PMID 30355250 DOI: 10.1161/Circresaha.118.313261  0.386
2018 Taylor DA, Elgalad A, Sampaio LC. What will it take before a bioengineered heart will be implanted in patients? Current Opinion in Organ Transplantation. PMID 30247170 DOI: 10.1097/Mot.0000000000000583  0.374
2018 Tang-Quan KR, Mehta NA, Sampaio LC, Taylor DA. Whole Cardiac Tissue Bioscaffolds. Advances in Experimental Medicine and Biology. 1098: 85-114. PMID 30238367 DOI: 10.1007/978-3-319-97421-7_5  0.356
2018 Lyu H, John M, Burkland D, Greet B, Xi Y, Sampaio L, Taylor D, Babakhani A, Razavi M. Leadless multisite pacing: A feasibility study using wireless power transfer using Langendorff rodent heart models. Journal of Cardiovascular Electrophysiology. PMID 30203520 DOI: 10.1111/Jce.13738  0.336
2018 Taylor DA, Frazier OH, Elgalad A, Hochman-Mendez C, Sampaio LC. Building a Total Bioartificial Heart: Harnessing Nature to Overcome the Current Hurdles. Artificial Organs. PMID 30044011 DOI: 10.1111/Aor.13336  0.428
2018 Bolli R, Hare JM, March KL, Pepine CJ, Willerson JT, Perin EC, Yang PC, Henry TD, Traverse JH, Mitrani RD, Khan A, Schulman IH, Taylor DA, DiFede DL, Lima JA, et al. Rationale and Design of the CONCERT-HF (Combination Of meseNchymal and c-kit Cardiac stEm cells as Regenerative Therapy for Heart Failure) Trial. Circulation Research. PMID 29703749 DOI: 10.1161/Circresaha.118.312978  0.445
2018 Jokerst JV, Cauwenberghs N, Kuznetsova T, Haddad F, Sweeney T, Hou J, Rosenberg-Hasson Y, Zhao E, Schutt R, Bolli R, Traverse JH, Pepine CJ, Henry TD, Schulman IH, Moyé L, ... Taylor DA, et al. Author Correction: Circulating Biomarkers to Identify Responders in Cardiac Cell therapy. Scientific Reports. 8: 4257. PMID 29511207 DOI: 10.1038/S41598-018-22121-2  0.313
2018 Perin EC, Taylor DA. Texas Heart Institute International Symposium on Cardiovascular Regenerative Medicine. Circulation Research. 122: 205-206. PMID 29348248 DOI: 10.1161/Circresaha.117.312100  0.384
2017 Traverse JH, Henry TD, Pepine CJ, Willerson JT, Chugh AR, Yang PC, Zhao D, Ellis SG, Forder JR, Perin EC, Penn MS, Hatzopoulos AK, Chambers JW, Baran K, Raveendran G, ... ... Taylor DA, et al. The TIME Trial - Effect of Timing of Stem Cell Delivery Following ST-Elevation Myocardial Infarction on the Recovery of Global and Regional Left Ventricular Function: Final 2-Year Analysis. Circulation Research. PMID 29208679 DOI: 10.1161/Circresaha.117.311466  0.403
2017 Jokerst JV, Cauwenberghs N, Kuznetsova T, Haddad F, Sweeney T, Hou J, Rosenberg-Hasson Y, Zhao E, Schutt R, Bolli R, Traverse JH, Pepine CJ, Henry TD, Schulman IH, Moyé L, ... Taylor DA, et al. Circulating Biomarkers to Identify Responders in Cardiac Cell therapy. Scientific Reports. 7: 4419. PMID 28667255 DOI: 10.1038/S41598-017-04801-7  0.372
2017 Shahrivari M, Wise E, Resende MM, Shuster JJ, Zhang J, Bolli R, Cooke JP, Hare JM, Henry TD, Khan A, Taylor DA, Traverse JH, Yang PC, Pepine CJ, Cogle CR. Peripheral Blood Cytokine Levels After Acute Myocardial Infarction: IL-1β and IL-6 Related Impairment of Bone Marrow Function. Circulation Research. PMID 28490433 DOI: 10.1161/Circresaha.116.309947  0.316
2017 Barac YD, Emrich F, Krutzwakd-Josefson E, Schrepfer S, Sampaio LC, Willerson JT, Robbins RC, Ciechanover A, Mohr FW, Aravot D, Taylor DA. The ubiquitin-proteasome system: A potential therapeutic target for heart failure. The Journal of Heart and Lung Transplantation : the Official Publication of the International Society For Heart Transplantation. PMID 28341100 DOI: 10.1016/J.Healun.2017.02.012  0.407
2017 Taylor DA, Parikh RB, Sampaio LC. Bioengineering Hearts: Simple yet Complex. Current Stem Cell Reports. 3: 35-44. PMID 28261549 DOI: 10.1007/S40778-017-0075-7  0.367
2017 Perin EC, Murphy MP, March KL, Bolli R, Loughran J, Yang PC, Leeper NJ, Dalman RL, Alexander JQ, Henry TD, Traverse JH, Pepine CJ, Anderson RD, Berceli S, Willerson JT, ... ... Taylor DA, et al. Evaluation of Cell Therapy on Exercise Performance and Limb Perfusion in Peripheral Artery Disease: The CCTRN Patients with Intermittent Claudication Injected with ALDH Bright Cells (PACE) Trial. Circulation. PMID 28209728 DOI: 10.1161/Circulationaha.116.025707  0.342
2017 Beigi F, Patel M, Morales-Garza MA, Winebrenner C, Gobin AS, Chau E, Sampaio LC, Taylor DA. Optimized Method for Isolating Highly Purified and Functional Porcine Aortic Endothelial and Smooth Muscle Cells. Journal of Cellular Physiology. PMID 28059438 DOI: 10.1002/Jcp.25764  0.304
2017 Taylor DA, Chandler AM, Gobin AS, Sampaio LC. Maximizing Cardiac Repair: Should We Focus on the Cells or on the Matrix? Circulation Research. 120: 30-32. PMID 28057787 DOI: 10.1161/Circresaha.116.309959  0.463
2017 Contreras A, Orozco AF, Resende M, Schutt RC, Traverse JH, Henry TD, Lai D, Cooke JP, Bolli R, Cohen ML, Moyé L, Pepine CJ, Yang PC, Perin EC, Willerson JT, ... Taylor DA, et al. Identification of cardiovascular risk factors associated with bone marrow cell subsets in patients with STEMI: a biorepository evaluation from the CCTRN TIME and LateTIME clinical trials. Basic Research in Cardiology. 112: 3. PMID 27882430 DOI: 10.1007/S00395-016-0592-Z  0.31
2017 Madonna R, Taylor D, Lyubomir L, Gobin AS, Guarnieri S, Mariggio MA, Giricz Z, Ferdinandy P, Fabrizio GD, Angelucci S, Boccio PD, Geng Y-, Perin E, Caterina RD, Willerson JT. P2554Transplantation of adipose tissue mesenchymal cells overexpressing telomerase and myocardin promotes revascularization and tissue repair in a murine model of myocardial infarction European Heart Journal. 38. DOI: 10.1093/Eurheartj/Ehx502.P2554  0.348
2016 Lee PF, Chau E, Cabello R, Yeh AT, Sampaio LC, Gobin AS, Taylor DA. Inverted orientation improves decellularization of whole porcine hearts. Acta Biomaterialia. PMID 27884776 DOI: 10.1016/J.Actbio.2016.11.047  0.394
2016 Bhatnagar A, Bolli R, Johnstone BH, Traverse JH, Henry TD, Pepine CJ, Willerson JT, Perin EC, Ellis SG, Zhao DX, Yang PC, Cooke JP, Schutt RC, Trachtenberg BH, Orozco A, ... ... Taylor DA, et al. Bone marrow cell characteristics associated with patient profile and cardiac performance outcomes in the LateTIME-Cardiovascular Cell Therapy Research Network (CCTRN) trial. American Heart Journal. 179: 142-50. PMID 27595689 DOI: 10.1016/J.Ahj.2016.06.018  0.422
2016 Sánchez PL, Fernández-Santos ME, Espinosa MA, González-Nicolas MA, Acebes JR, Costanza S, Moscoso I, Rodríguez H, García J, Romero J, Kren SM, Bermejo J, Yotti R, Del Villar CP, Sanz-Ruiz R, ... ... Taylor DA, et al. Data from acellular human heart matrix. Data in Brief. 8: 211-9. PMID 27331090 DOI: 10.1016/J.Dib.2016.04.069  0.424
2016 Garreta E, de Oñate L, Fernández-Santos ME, Oria R, Tarantino C, Climent AM, Marco A, Samitier M, Martínez E, Valls-Margarit M, Matesanz R, Taylor DA, Fernández-Avilés F, Izpisua Belmonte JC, Montserrat N. Myocardial commitment from human pluripotent stem cells: Rapid production of human heart grafts. Biomaterials. 98: 64-78. PMID 27179434 DOI: 10.1016/J.Biomaterials.2016.04.003  0.415
2016 Madonna R, Robertson A, Campagnolo P, Taylor D, Lyubomir P, Gobin A, Geng Y, Ferdinandy P, Caterina RD, Cabriera M, Perin E, Willerson J, Mohammed T, Cartwright E, Oceandy D, et al. Tissue Engineering and Repair of the Damaged Heart490Transplantation of adipose mesenchymal cells overexpressing telomerase and myocardin preserved cardiac function and promoted tissue repair in murine myocardial infarction491Targeting the hippo signalling pathway to enhance the therapeutic potential of iPS-derived cardiomyocytes492Porous silicon nanoneedles for localised in situ gene transfer for cardiac therapy Cardiovascular Research. 111. DOI: 10.1093/Cvr/Cvw153  0.451
2015 Gubareva EA, Sjöqvist S, Gilevich IV, Sotnichenko AS, Kuevda EV, Lim ML, Feliu N, Lemon G, Danilenko KA, Nakokhov RZ, Gumenyuk IS, Grigoriev TE, Krasheninnikov SV, Pokhotko AG, Basov AA, ... ... Taylor DA, et al. Orthotopic transplantation of a tissue engineered diaphragm in rats. Biomaterials. 77: 320-335. PMID 26618750 DOI: 10.1016/J.Biomaterials.2015.11.020  0.37
2015 Willerson JT, Cabreira-Hansen MG, Taylor DA, Perin EC. Changing of the guard? European Heart Journal. 36: 1711-3. PMID 26022009 DOI: 10.1093/Eurheartj/Ehv219  0.417
2015 Sánchez PL, Fernández-Santos ME, Costanza S, Climent AM, Moscoso I, Gonzalez-Nicolas MA, Sanz-Ruiz R, Rodríguez H, Kren SM, Garrido G, Escalante JL, Bermejo J, Elizaga J, Menarguez J, Yotti R, ... ... Taylor DA, et al. Acellular human heart matrix: A critical step toward whole heart grafts. Biomaterials. 61: 279-89. PMID 26005766 DOI: 10.1016/J.Biomaterials.2015.04.056  0.447
2015 Schutt RC, Trachtenberg BH, Cooke JP, Traverse JH, Henry TD, Pepine CJ, Willerson JT, Perin EC, Ellis SG, Zhao DX, Bhatnagar A, Johnstone BH, Lai D, Resende M, Ebert RF, ... ... Taylor DA, et al. Bone marrow characteristics associated with changes in infarct size after STEMI: a biorepository evaluation from the CCTRN TIME trial. Circulation Research. 116: 99-107. PMID 25406300 DOI: 10.1161/Circresaha.116.304710  0.379
2015 Madonna R, Taylor D, Lyubomir P, Gobin AS, Teberino MA, Geng YJ, Ferdinandy P, Caterina RD, Cabriera M, Perin E, Willerson JT. Transplantation of adipose tissue mesenchymal cells overexpressing telomerase and myocardin promotes activation of the cardiomyogenic program and vasculogenesis, and preserves cardiac function in a murine model of myocardial infarction Vascular Pharmacology. 75: 60. DOI: 10.1016/J.Vph.2015.11.047  0.402
2014 Perin EC, Murphy M, Cooke JP, Moyé L, Henry TD, Bettencourt J, Gahremanpour A, Leeper N, Anderson RD, Hiatt WR, Lima JA, Venkatesh B, Sayre SL, Vojvodic RW, Taylor DA, et al. Rationale and design for PACE: patients with intermittent claudication injected with ALDH bright cells. American Heart Journal. 168: 667-73. PMID 25440794 DOI: 10.1016/J.Ahj.2014.07.021  0.371
2014 Willerson JT, Taylor D, Perin EC. Till Truth Makes All Things Plain: Human Hearts and Stem Cells Circulation Research. 115: 908-910. PMID 25378531 DOI: 10.1161/Circresaha.114.305340  0.462
2014 Taylor DA, Sampaio LC, Gobin A. Building new hearts: a review of trends in cardiac tissue engineering. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 14: 2448-59. PMID 25293671 DOI: 10.1111/Ajt.12939  0.388
2014 Cogle CR, Wise E, Meacham AM, Zierold C, Traverse JH, Henry TD, Perin EC, Willerson JT, Ellis SG, Carlson M, Zhao DX, Bolli R, Cooke JP, Anwaruddin S, Bhatnagar A, ... ... Taylor DA, et al. Detailed analysis of bone marrow from patients with ischemic heart disease and left ventricular dysfunction: BM CD34, CD11b, and clonogenic capacity as biomarkers for clinical outcomes. Circulation Research. 115: 867-74. PMID 25136078 DOI: 10.1161/Circresaha.115.304353  0.429
2014 Simari RD, Pepine CJ, Traverse JH, Henry TD, Bolli R, Spoon DB, Yeh E, Hare JM, Schulman IH, Anderson RD, Lambert C, Sayre SL, Taylor DA, Ebert RF, Moyé LA. Bone marrow mononuclear cell therapy for acute myocardial infarction: a perspective from the cardiovascular cell therapy research network. Circulation Research. 114: 1564-8. PMID 24812350 DOI: 10.1161/Circresaha.114.303720  0.388
2014 Sjöqvist S, Jungebluth P, Lim ML, Haag JC, Gustafsson Y, Lemon G, Baiguera S, Burguillos MA, Del Gaudio C, Rodríguez AB, Sotnichenko A, Kublickiene K, Ullman H, Kielstein H, Damberg P, ... ... Taylor DA, et al. Experimental orthotopic transplantation of a tissue-engineered oesophagus in rats. Nature Communications. 5: 3562. PMID 24736316 DOI: 10.1038/Ncomms4562  0.353
2014 Ascheim DD, Gelijns AC, Goldstein D, Moye LA, Smedira N, Lee S, Klodell CT, Szady A, Parides MK, Jeffries NO, Skerrett D, Taylor DA, Rame JE, Milano C, Rogers JG, et al. Mesenchymal precursor cells as adjunctive therapy in recipients of contemporary left ventricular assist devices. Circulation. 129: 2287-96. PMID 24682346 DOI: 10.1161/Circulationaha.113.007412  0.445
2014 Robertson MJ, Dries-Devlin JL, Kren SM, Burchfield JS, Taylor DA. Optimizing recellularization of whole decellularized heart extracellular matrix. Plos One. 9: e90406. PMID 24587354 DOI: 10.1371/Journal.Pone.0090406  0.425
2014 Olson RE, Vojvodic RW, Bettencourt J, Handberg EM, Szymanski E, Smith D, LaRock J, Sharma SV, Taylor DA, Henry TD. Recruiting for Acute Myocardial Infarction Cell Therapy Trials Clinical Researcher. 28: 71-77. DOI: 10.14524/Cr-14-0008  0.412
2013 Madonna R, Taylor DA, Geng YJ, De Caterina R, Shelat H, Perin EC, Willerson JT. Transplantation of mesenchymal cells rejuvenated by the overexpression of telomerase and myocardin promotes revascularization and tissue repair in a murine model of hindlimb ischemia. Circulation Research. 113: 902-14. PMID 23780385 DOI: 10.1161/Circresaha.113.301690  0.362
2013 Hare JM, Bolli R, Cooke JP, Gordon DJ, Henry TD, Perin EC, March KL, Murphy MP, Pepine CJ, Simari RD, Skarlatos SI, Traverse JH, Willerson JT, Szady AD, Taylor DA, et al. Phase II clinical research design in cardiology: learning the right lessons too well: observations and recommendations from the Cardiovascular Cell Therapy Research Network (CCTRN). Circulation. 127: 1630-5. PMID 23588961 DOI: 10.1161/Circulationaha.112.000779  0.318
2013 Seguin A, Baccari S, Holder-Espinasse M, Bruneval P, Carpentier A, Taylor DA, Martinod E. Tracheal regeneration: evidence of bone marrow mesenchymal stem cell involvement. The Journal of Thoracic and Cardiovascular Surgery. 145: 1297-1304.e2. PMID 23111025 DOI: 10.1016/J.Jtcvs.2012.09.079  0.376
2013 Syedain ZH, Bradee AR, Kren S, Taylor DA, Tranquillo RT. Decellularized tissue-engineered heart valve leaflets with recellularization potential. Tissue Engineering. Part A. 19: 759-69. PMID 23088577 DOI: 10.1089/Ten.Tea.2012.0365  0.382
2013 Henry TD, Traverse JH, Pepine CJ, Willerson JT, Ellis S, Zhao DX, Simpson L, Perin E, Penn M, Baran KW, Chambers J, Lambert C, Raveendran G, Simon D, Gee AP, ... ... Taylor DA, et al. TCT-823 Results from LateTIME: A Randomized, Placebo Controlled Trial of Intracoronary Stem Cell Delivery Two to Three Weeks Following Acute Myocardial Infarction from the Cardiovascular Cell Therapy Research Network Journal of the American College of Cardiology. 62: B249. DOI: 10.1016/J.Jacc.2013.08.1576  0.422
2012 Davis BH, Morimoto Y, Sample C, Olbrich K, Leddy HA, Guilak F, Taylor DA. Effects of myocardial infarction on the distribution and transport of nutrients and oxygen in porcine myocardium. Journal of Biomechanical Engineering. 134: 101005. PMID 23083196 DOI: 10.1115/1.4007455  0.382
2012 Perin EC, Willerson JT, Pepine CJ, Henry TD, Ellis SG, Zhao DX, Silva GV, Lai D, Thomas JD, Kronenberg MW, Martin AD, Anderson RD, Traverse JH, Penn MS, Anwaruddin S, ... ... Taylor DA, et al. Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial. Jama. 307: 1717-26. PMID 22447880 DOI: 10.1001/Jama.2012.418  0.396
2012 Baiguera S, Del Gaudio C, Jaus MO, Polizzi L, Gonfiotti A, Comin CE, Bianco A, Ribatti D, Taylor DA, Macchiarini P. Long-term changes to in vitro preserved bioengineered human trachea and their implications for decellularized tissues. Biomaterials. 33: 3662-72. PMID 22349289 DOI: 10.1016/J.Biomaterials.2012.01.064  0.309
2012 Richman S, Gee AP, McKenna DH, Traverse JH, Henry TD, Fisk D, Pepine CJ, Bloom J, Willerson JT, Prater K, Zhao D, Koç JR, Anwaruddin S, Taylor DA, Cogle CR, et al. Factors affecting the turnaround time for manufacturing, testing, and release of cellular therapy products prepared at multiple sites in support of multicenter cardiovascular regenerative medicine protocols: a Cardiovascular Cell Therapy Research Network (CCTRN) study. Transfusion. 52: 2225-33. PMID 22320233 DOI: 10.1111/J.1537-2995.2011.03543.X  0.379
2012 Painovich J, Phan A, Li N, Chowdhury S, Dhawan S, Taylor D, Marban E, Merz CB. P02.110. Effect of traditional acupuncture on circulating endothelial progenitor cells in patients with coronary heart disease Bmc Complementary and Alternative Medicine. 12. DOI: 10.1186/1472-6882-12-S1-P167  0.342
2012 Sanchez PL, Fernandez-Santos ME, Costanza S, Rodríguez-Abella H, Kren S, Garrido G, Escalante JL, Matesanz R, Taylor D, Francisco F. Characterization And Biocompatibility Of Perfusion-Decellularized Human Heart Matrix: Toward Bioengineering Perfusable Human Heart Grafts Journal of the American College of Cardiology. 59. DOI: 10.1016/S0735-1097(12)60858-4  0.382
2011 Zierold C, Carlson MA, Obodo UC, Wise E, Piazza VA, Meeks MW, Vojvodic RW, Baraniuk S, Henry TD, Gee AP, Ellis SG, Moyé LA, Pepine CJ, Cogle CR, Taylor DA. Developing mechanistic insights into cardiovascular cell therapy: Cardiovascular Cell Therapy Research Network Biorepository Core Laboratory rationale. American Heart Journal. 162: 973-80. PMID 22137069 DOI: 10.1016/J.Ahj.2011.05.024  0.422
2011 Traverse JH, Henry TD, Ellis SG, Pepine CJ, Willerson JT, Zhao DX, Forder JR, Byrne BJ, Hatzopoulos AK, Penn MS, Perin EC, Baran KW, Chambers J, Lambert C, Raveendran G, ... ... Taylor DA, et al. Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial. Jama. 306: 2110-9. PMID 22084195 DOI: 10.1001/Jama.2011.1670  0.408
2011 Taylor DA. Cell therapy-a 21st century hope for treating cardiovascular disease-a five-year retrospective and predictive view. The American Heart Hospital Journal. 9: E24-7. PMID 21823072 DOI: 10.15420/Ahhj.2011.9.1.24  0.319
2011 Badylak SF, Taylor D, Uygun K. Whole-organ tissue engineering: decellularization and recellularization of three-dimensional matrix scaffolds. Annual Review of Biomedical Engineering. 13: 27-53. PMID 21417722 DOI: 10.1146/Annurev-Bioeng-071910-124743  0.338
2011 Henry TD, Taylor D. Skeletal myoblasts for myocardial regeneration in patients with congestive heart failure: where have all the answers gone? Eurointervention. 6: 789-793. PMID 21252009 DOI: 10.4244/Eijv6I7A135  0.375
2010 Traverse JH, Henry TD, Vaughan DE, Ellis SG, Pepine CJ, Willerson JT, Zhao DX, Simpson LM, Penn MS, Byrne BJ, Perin EC, Gee AP, Hatzopoulos AK, McKenna DH, Forder JR, ... Taylor DA, et al. LateTIME: a phase-II, randomized, double-blinded, placebo-controlled, pilot trial evaluating the safety and effect of administration of bone marrow mononuclear cells 2 to 3 weeks after acute myocardial infarction. Texas Heart Institute Journal / From the Texas Heart Institute of St. Luke's Episcopal Hospital, Texas Children's Hospital. 37: 412-20. PMID 20844613  0.347
2010 Gee AP, Richman S, Durett A, McKenna D, Traverse J, Henry T, Fisk D, Pepine C, Bloom J, Willerson J, Prater K, Zhao D, Koç JR, Ellis S, Taylor D, et al. Multicenter cell processing for cardiovascular regenerative medicine applications: the Cardiovascular Cell Therapy Research Network (CCTRN) experience. Cytotherapy. 12: 684-91. PMID 20524773 DOI: 10.3109/14653249.2010.487900  0.351
2010 Bairey Merz CN, Mark S, Boyan BD, Jacobs AK, Shah PK, Shaw LJ, Taylor D, Marbán E. Proceedings from the scientific symposium: Sex differences in cardiovascular disease and implications for therapies. Journal of Women's Health (2002). 19: 1059-72. PMID 20500123 DOI: 10.1089/Jwh.2009.1695  0.324
2010 Dib N, Menasche P, Bartunek JJ, Zeiher AM, Terzic A, Chronos NA, Henry TD, Peters NS, Fernández-Avilés F, Yacoub M, Sanborn TA, Demaria A, Schatz RA, Taylor DA, Fuchs S, et al. Recommendations for successful training on methods of delivery of biologics for cardiac regeneration: a report of the International Society for Cardiovascular Translational Research. Jacc. Cardiovascular Interventions. 3: 265-75. PMID 20298983 DOI: 10.1016/J.Jcin.2009.12.013  0.369
2010 Segal MS, Grant M, Taylor D, Cogel C, Moyé L, Pepine C. BONE MARROW EPC FUNCTION RELATIVE TO TIME OF COLLECTION AFTER ACUTE MYOCARDIAL INFARCTION Journal of the American College of Cardiology. 55: A24.E231. DOI: 10.1016/S0735-1097(10)60232-X  0.32
2009 Taylor DA. From stem cells and cadaveric matrix to engineered organs. Current Opinion in Biotechnology. 20: 598-605. PMID 19914057 DOI: 10.1016/J.Copbio.2009.10.016  0.436
2009 Taylor DA, Robertson MJ. The basics of cell therapy to treat cardiovascular disease: one cell does not fit all. Revista Espaã±Ola De Cardiologã­A. 62: 1032-44. PMID 19712624 DOI: 10.1016/S1885-5857(09)73269-4  0.397
2009 Traverse JH, Henry TD, Vaughan DE, Vaughn DE, Ellis SG, Pepine CJ, Willerson JT, Zhao DX, Piller LB, Penn MS, Byrne BJ, Perin EC, Gee AP, Hatzopoulos AK, McKenna DH, ... ... Taylor DA, et al. Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction. American Heart Journal. 158: 356-63. PMID 19699857 DOI: 10.1016/J.Ahj.2009.06.009  0.426
2008 Taylor DA, Zenovich AG. Cardiovascular cell therapy and endogenous repair. Diabetes, Obesity & Metabolism. 10: 5-15. PMID 18834428 DOI: 10.1111/J.1463-1326.2008.00937.X  0.431
2008 Zenovich AG, Taylor DA. Atherosclerosis as a disease of failed endogenous repair. Frontiers in Bioscience : a Journal and Virtual Library. 13: 3621-36. PMID 18508460 DOI: 10.2741/2954  0.386
2008 Ott HC, Matthiesen TS, Goh SK, Black LD, Kren SM, Netoff TI, Taylor DA. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nature Medicine. 14: 213-21. PMID 18193059 DOI: 10.1038/Nm1684  0.427
2008 McCue JD, Swingen C, Feldberg T, Caron G, Kolb A, Denucci C, Prabhu S, Motilall R, Breviu B, Taylor DA. The real estate of myoblast cardiac transplantation: negative remodeling is associated with location. The Journal of Heart and Lung Transplantation : the Official Publication of the International Society For Heart Transplantation. 27: 116-23. PMID 18187097 DOI: 10.1016/J.Healun.2007.10.011  0.38
2007 Davis BH, Schroeder T, Yarmolenko PS, Guilak F, Dewhirst MW, Taylor DA. An in vitro system to evaluate the effects of ischemia on survival of cells used for cell therapy. Annals of Biomedical Engineering. 35: 1414-24. PMID 17417737 DOI: 10.1007/S10439-007-9301-2  0.391
2007 Taylor DA, Zenovich AG. Cell therapy for left ventricular remodeling. Current Heart Failure Reports. 4: 3-10. PMID 17386179 DOI: 10.1007/S11897-007-0019-0  0.41
2007 Ott HC, Matthiesen TS, Brechtken J, Grindle S, Goh SK, Nelson W, Taylor DA. The adult human heart as a source for stem cells: repair strategies with embryonic-like progenitor cells. Nature Clinical Practice. Cardiovascular Medicine. 4: S27-39. PMID 17230213 DOI: 10.1038/Ncpcardio0771  0.438
2006 Ott HC, Taylor DA. From cardiac repair to cardiac regeneration--ready to translate? Expert Opinion On Biological Therapy. 6: 867-78. PMID 16918254 DOI: 10.1517/14712598.6.9.867  0.473
2006 Taylor DA. Cell therapy: a 21st-century hope for treating cardiovascular disease--what do the next 5 years hold? The American Heart Hospital Journal. 4: 219-21. PMID 16894261 DOI: 10.1111/J.1541-9215.2006.05579.X  0.335
2006 Kunz GA, Liang G, Cuculi F, Cuculoski F, Gregg D, Vata KC, Shaw LK, Goldschmidt-Clermont PJ, Dong C, Taylor DA, Peterson ED. Circulating endothelial progenitor cells predict coronary artery disease severity. American Heart Journal. 152: 190-5. PMID 16824855 DOI: 10.1016/J.Ahj.2006.02.001  0.305
2006 Ott HC, Brechtken J, Swingen C, Feldberg TM, Matthiesen TS, Barnes SA, Nelson W, Taylor DA. Robotic minimally invasive cell transplantation for heart failure. The Journal of Thoracic and Cardiovascular Surgery. 132: 170-3. PMID 16798327 DOI: 10.1016/J.Jtcvs.2006.02.017  0.442
2006 Ott HC, Matthiessen TS, Brechtken J, Xin X, Nelson W, Goh S, Taylor DA. Abstract25: A novel population of Flk1+/CD31-adult derived cardiac progenitor cells is capable of functional myocardial repair Journal of Heart and Lung Transplantation. 25. DOI: 10.1016/J.Healun.2005.11.026  0.353
2005 Ott HC, Davis BH, Taylor DA. Cell therapy for heart failure--muscle, bone marrow, blood, and cardiac-derived stem cells. Seminars in Thoracic and Cardiovascular Surgery. 17: 348-60. PMID 16428043 DOI: 10.1053/J.Semtcvs.2005.09.004  0.483
2005 He KL, Yi GH, Sherman W, Zhou H, Zhang GP, Gu A, Kao R, Haimes HB, Harvey J, Roos E, White D, Taylor DA, Wang J, Burkhoff D. Autologous skeletal myoblast transplantation improved hemodynamics and left ventricular function in chronic heart failure dogs. The Journal of Heart and Lung Transplantation : the Official Publication of the International Society For Heart Transplantation. 24: 1940-9. PMID 16297802 DOI: 10.1016/J.Healun.2005.02.024  0.406
2005 Ott HC, McCue J, Taylor DA. Cell-based cardiovascular repair--the hurdles and the opportunities. Basic Research in Cardiology. 100: 504-17. PMID 16237510 DOI: 10.1007/S00395-004-0558-Z  0.381
2005 van den Bos EJ, Thompson RB, Wagner A, Mahrholdt H, Morimoto Y, Thomson LE, Wang LH, Duncker DJ, Judd RM, Taylor DA. Functional assessment of myoblast transplantation for cardiac repair with magnetic resonance imaging. European Journal of Heart Failure. 7: 435-43. PMID 15921777 DOI: 10.1016/J.Ejheart.2003.12.022  0.321
2005 Thompson RB, van den Bos EJ, Davis BH, Morimoto Y, Craig D, Sutton BS, Glower DD, Taylor DA. Intracardiac transplantation of a mixed population of bone marrow cells improves both regional systolic contractility and diastolic relaxation. The Journal of Heart and Lung Transplantation : the Official Publication of the International Society For Heart Transplantation. 24: 205-14. PMID 15701439 DOI: 10.1016/J.Healun.2003.10.021  0.411
2005 Pedrotty DM, Koh J, Davis BH, Taylor DA, Wolf P, Niklason LE. Engineering skeletal myoblasts: roles of three-dimensional culture and electrical stimulation. American Journal of Physiology. Heart and Circulatory Physiology. 288: H1620-6. PMID 15550526 DOI: 10.1152/Ajpheart.00610.2003  0.37
2004 van den Bos EJ, Davis BH, Taylor DA. Transplantation of skeletal myoblasts for cardiac repair. The Journal of Heart and Lung Transplantation : the Official Publication of the International Society For Heart Transplantation. 23: 1217-27. PMID 15539118 DOI: 10.1016/J.Healun.2003.10.015  0.452
2004 Taylor DA. Cell-based myocardial repair: how should we proceed? International Journal of Cardiology. 95: S8-12. PMID 15336836 DOI: 10.1016/S0167-5273(04)90003-4  0.475
2004 Vainorius E, Sutton BS, Morimoto Y, Davis BH, Taylor DA. 1064-188 Bone marrow mononuclear cell therapy reduces post-angioplasty neointimal formation in rabbits Journal of the American College of Cardiology. 43. DOI: 10.1016/S0735-1097(04)91975-4  0.326
2004 Morimoto Y, Klem I, Vainorius E, Sutton BS, Davis BH, Judd RM, Taylor DA. 1144-134 Direct comparison of bone marrow stromal versus mononuclear cells in murine cardiac function after cellular cardiomyoplasty Journal of the American College of Cardiology. 43: 2203. DOI: 10.1016/S0735-1097(04)90933-3  0.375
2004 Soliman AM, Krucoff MW, Crater S, Morimoto Y, Taylor DA. 1059-23 Cell location may be a primary determinant of safety after myoblast transplantation into the infarcted heart Journal of the American College of Cardiology. 43. DOI: 10.1016/S0735-1097(04)90062-9  0.406
2004 Guy L, Morimoto Y, Iacampo S, Fortin AS, Davis BH, Leclerc G, Taylor DA. 927. Cell Therapy To Restore Perfusion and Cardiac Function in Infarcted Heart Is Improved by EPAS1 Gene Transfer Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.853  0.389
2003 Thompson RB, Emani SM, Davis BH, van den Bos EJ, Morimoto Y, Craig D, Glower D, Taylor DA. Comparison of intracardiac cell transplantation: autologous skeletal myoblasts versus bone marrow cells. Circulation. 108: II264-71. PMID 12970244 DOI: 10.1161/01.Cir.0000087657.29184.9B  0.425
2003 Rauscher FM, Goldschmidt-Clermont PJ, Davis BH, Wang T, Gregg D, Ramaswami P, Pippen AM, Annex BH, Dong C, Taylor DA. Aging, progenitor cell exhaustion, and atherosclerosis. Circulation. 108: 457-63. PMID 12860902 DOI: 10.1161/01.Cir.0000082924.75945.48  0.305
2003 Thompson RB, Emani S, Colgrove S, Davis BH, Craig D, Morimoto Y, Glower D, Taylor DA. Transplantation of a mixed population of bone marrow-derived progenitor cells improves regional systolic function in a rabbit model of cryoinjured myocardium Journal of Heart and Lung Transplantation. 22. DOI: 10.1016/S1053-2498(02)00695-2  0.412
2002 Dai Q, Thompson MA, Pippen AM, Cherwek H, Taylor DA, Annex BH. Alterations in endothelial cell proliferation and apoptosis contribute to vascular remodeling following hind-limb ischemia in rabbits. Vascular Medicine (London, England). 7: 87-91. PMID 12402988 DOI: 10.1191/1358863X02Vm430Oa  0.311
2002 Dib N, Diethrich EB, Campbell A, Goodwin N, Robinson B, Gilbert J, Hobohm DW, Taylor DA. Endoventricular transplantation of allogenic skeletal myoblasts in a porcine model of myocardial infarction. Journal of Endovascular Therapy : An Official Journal of the International Society of Endovascular Specialists. 9: 313-9. PMID 12096946 DOI: 10.1177/152660280200900310  0.389
2002 Taylor DA, Hruban R, Rodriguez ER, Goldschmidt-Clermont PJ. Cardiac chimerism as a mechanism for self-repair: does it happen and if so to what degree? Circulation. 106: 2-4. PMID 12093758 DOI: 10.1161/01.Cir.0000024386.99599.4A  0.448
2002 Badylak SF, Grompe M, Caplan AI, Greisler HP, Guldberg RE, Taylor DA. In vivo remodeling: breakout session summary. Annals of the New York Academy of Sciences. 961: 319-22. PMID 12081929 DOI: 10.1111/J.1749-6632.2002.Tb03113.X  0.305
2002 Taylor DA. Is in vivo remodeling necessary or sufficient for cellular repair of the heart? Annals of the New York Academy of Sciences. 961: 315-8. PMID 12081928 DOI: 10.1111/J.1749-6632.2002.Tb03112.X  0.374
2002 Scarborough JE, Colgrove SL, Lowe M, Liao L, Taylor DA. Autologous skeletal myoblast transplantation prevents ventricular dilatation in a porcine model of myocardial infarction Journal of Heart and Lung Transplantation. 21: 163. DOI: 10.1016/S1053-2498(01)00734-3  0.38
2001 Taylor DA. Cellular cardiomyoplasty with autologous skeletal myoblasts for ischemic heart disease and heart failure. Current Controlled Trials in Cardiovascular Medicine. 2: 208-210. PMID 11806797 DOI: 10.1186/Cvm-2-5-208  0.472
1999 Atkins BZ, Hueman MT, Meuchel JM, Cottman MJ, Hutcheson KA, Taylor DA. Myogenic cell transplantation improves in vivo regional performance in infarcted rabbit myocardium. The Journal of Heart and Lung Transplantation : the Official Publication of the International Society For Heart Transplantation. 18: 1173-80. PMID 10612375 DOI: 10.1016/S1053-2498(99)00096-0  0.429
1999 Cherwek DH, Hopkins MB, Hutcheson KA, Urbaniak JR, Taylor DA. Relieving exercise intolerance secondary to heart failure: Myoblast-mediated delivery of the vascular endothelial growth factor, VEGF, to ischemic skeletal muscle Journal of Cardiac Failure. 5: 27. DOI: 10.1016/S1071-9164(99)91441-0  0.31
1999 Hueman MT, Atkins BZ, Hutcheson KA, Meuchel JM, Cottman MJ, Annex BH, Glower DD, Taylor DA. Angiogenic rescue of regional myocardial function: Delivery of vascular endothelial growth factor to cryoinjured rabbit heart improves myocardial compliance Journal of Cardiac Failure. 5: 26. DOI: 10.1016/S1071-9164(99)91439-2  0.365
1999 Atkins BZ, Hutcheson KA, Hueman MT, Cottman MJ, Meuchel JM, Glower DD, Taylor DA. Engrafted autologous skeletal myoblasts improve myocardial performance in severely infarcted rabbit myocardium Journal of Cardiac Failure. 5: 24. DOI: 10.1016/S1071-9164(99)91431-8  0.355
1999 Hutcheson KA, Atkins BZ, Hopkins MB, Glower DD, Taylor DA. Significance of cell type in regenerating functional myocardium: In vivo comparison of myoblasts vs. fibroblasts in a rabbit model of cell transplant to cryoinjured myocardium Journal of Cardiac Failure. 5: 23. DOI: 10.1016/S1071-9164(99)91425-2  0.397
1998 Lewis CW, Atkins BZ, Hutcheson KA, Gillen CT, Reedy MC, Glower DD, Taylor DA. A load-independent in vivo model for evaluating therapeutic interventions in injured myocardium. The American Journal of Physiology. 275: H1834-44. PMID 9815092 DOI: 10.1152/Ajpheart.1998.275.5.H1834  0.358
1998 Taylor DA, Atkins BZ, Hungspreugs P, Jones TR, Reedy MC, Hutcheson KA, Glower DD, Kraus WE. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nature Medicine. 4: 929-33. PMID 9701245 DOI: 10.1038/nm0898-929  0.348
1998 Abdel-aleem S, Louis JS, Hendrickson SC, El-Shewy HM, El-Dawy K, Taylor DA, Lowe JE. Regulation of carbohydrate and fatty acid utilization by L-carnitine during cardiac development and hypoxia Molecular and Cellular Biochemistry. 180: 95-103. DOI: 10.1007/978-1-4615-5687-9_10  0.319
1996 Silvestry SC, Taylor DA, Lilly RE, Atkins BZ, Marathe US, Davis JW, Kraus W, Glower DD. The in vivo quantification of myocardial performance in rabbits: a model for evaluation of cardiac gene therapy. Journal of Molecular and Cellular Cardiology. 28: 815-23. PMID 8762021 DOI: 10.1006/Jmcc.1996.0076  0.343
Show low-probability matches.